Skip to main content

Advertisement

SpringerLink
Log in

Nuclear cardiology for a cardiothoracic surgeon

  • Review Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Cardiac surgeons are commonly faced with issues regarding the balance between the potential risk and the potential benefit of a surgical procedure. Nuclear cardiology procedures such as single-photon emission computed tomography and positron emission tomography provide the surgeon with objective information that augments standard clinical and angiographic assessments related to the diagnosis, prognosis, and potential benefit from any intervention. Myocardial perfusion is imaged with the use of radiopharmaceuticals that accumulate rapidly in the myocardium in proportion to the myocardial blood flow. Radionuclide lung imaging most commonly involves the demonstration of pulmonary perfusion using technetium-99 m macro aggregate albumin (Tc-99 m MAA), as well as the assessment of ventilation using inspired inert gas, usually xenon, or Tc-99 m-labelled aerosols. Nuclear cardiology is extensively used as a part of the work-up of ischemic heart disease and cardiac failure in deciding the optimal therapeutic strategy with its ability to predict the severity of the disease. It has also proved extremely useful in the management of congenital heart disease and the diagnosis of pulmonary embolism, among many other applications. Myocardial perfusion imaging is a basic adjunct to the noninvasive assessment of patients with stable angina, baseline electrocardiogram (ECG) abnormalities, post-revascularisation assessment, and heart failure. This review article covers a summary of basic concepts of nuclear cardiology about what a cardiac surgeon should be aware of. To many, it is just a perfusion test, but the versatility, reliability, and future of the technology are without a doubt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and material

Yes.

Code availability

Not applicable.

References

  1. Sabharwal NK, Lahiri A. Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease. Heart. 2003;89:1291–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Verberne HJ, Acampa W, Anagnostopoulos C, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42:1929–40.

  3. Des Prez RD, Shaw LJ, Gillespie RL, et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature. J Nucl Cardiol. 2005;12:750–9.

  4. Hansen CL, Goldstein RA, Akinboboye OO, et al. Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol. 2007;14:e39-60.

  5. Paul AK, Nabi HA. Gated myocardial perfusion SPECT: basic principles, technical aspects, and clinical applications. J Nucl Med Technol. 2004;32:179–87.

    PubMed  Google Scholar 

  6. Arumugam P, Tout D, Tonge C. Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography. Br Med Bull. 2013;107:87–100.

    Article  CAS  PubMed  Google Scholar 

  7. Garcia EV. Quantitative nuclear cardiology: we are almost there. J Nucl Cardiol. 2012;19:424–37.

    Article  PubMed  Google Scholar 

  8. Duvall WL, Hiensch RJ, Levine EJ, Croft LB, Henzlova MJ. The prognosis of a normal Tl-201 stress-only SPECT MPI study. J Nucl Cardiol. 2012;19:914–21.

    Article  PubMed  Google Scholar 

  9. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol. 1993;72:1015–9.

    Article  CAS  PubMed  Google Scholar 

  10. Davidson CQ, Phenix CP, Taj TC, Khaper N, Lees SJ. Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation. Am J Nucl Med Mol Imaging. 2018;8:200–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol. 2010;17:709–18.

  12. El-Ali HH, Palmer J, Carlsson M, Edenbrandt L, Ljungberg M. Comparison of 1- and 2-day protocols for myocardial SPECT: a Monte Carlo study. Clin Physiol Funct Imaging. 2005;25:189–95.

  13. Hendel RC, Berman DS, Di Carli MF,et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53:2201–29.

  14. Ejlersen JA, May O, Mortensen J, Nielsen GL, Lauridsen JF, Allan J. Stress-only myocardial perfusion scintigraphy: a prospective study on the accuracy and observer agreement with quantitative coronary angiography as the gold standard. Nucl Med Commun. 2017;38:904–11.

    Article  PubMed  Google Scholar 

  15. Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606–39.

    Article  PubMed  Google Scholar 

  16. Oddstig J, Hedeer F, Jögi J, Carlsson M, Hindorf C, Engblom H. Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera. J Nucl Cardiol. 2013;20:38–44.

    Article  PubMed  Google Scholar 

  17. Mahmarian JJ, Shaw LJ, Filipchuk NG, et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol.2006;48:2448–57.

  18. Wu M-T, Huang Y-L, Hsieh K-S,  et al. Influence of pulmonary regurgitation inequality on differential perfusion of the lungs in tetralogy of Fallot after repair: a phase-contrast magnetic resonance imaging and perfusion scintigraphy study. J Am Coll Cardiol. 2007;49:1880–6.

  19. Dvorak RA, Brown RKJ, Corbett JR. Interpretation of SPECT/CT myocardial perfusion images: common artifacts and quality control techniques. Radiographics. 2011;31:2041-57.

  20. Murthy VL, Bateman TM, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET. Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018;25:269–97.

  21. Bax JJ, van der Wall EE. Evaluation of myocardial viability in chronic ischemic cardiomyopathy. Int J Cardiovasc Imaging. 2003;19:137–140.

  22. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528–1534.

  23. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997–1004.

  24. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8.

    Article  PubMed  Google Scholar 

  25. Beanlands RSB, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease. a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.

  26. Carson P, Wertheimer J, Miller A, et al. The STICH Trial (Surgical Treatment for Ischemic Heart Failure); mode-of-death results. JACC Heart Fail. 2013;1:400–8.

  27. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.

    Article  PubMed  Google Scholar 

  28. Abidov A, Germano G, Berman DS. Transient ischemic dilation ratio: a universal high-risk diagnostic marker in myocardial perfusion imaging. J Nucl Cardiol. 2007;14:497–500.

    Article  PubMed  Google Scholar 

  29. Ling LF, Marwick TH, Flores DR, et al. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013;6:363–72.

  30. Gould KL. Coronary flow reserve and pharmacologic stress perfusion imaging: beginnings and evolution. JACC Cardiovasc Imaging. 2009;2:664–9. 

  31. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91.

    Article  PubMed  Google Scholar 

  32. Panza JA, Ellis AM, Al-Khalidi HR, et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N Engl J Med. 2019;381:739–748.

  33. Mc Ardle BA, Beanlands RSB. Myocardial viability: whom, what, why, which, and how? Can J Cardiol.2013;29:399–402.

  34. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC Guidelines for the clinical use of Cardiac Radionuclide Imaging-Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the clinical use of Cardiac Radionuclide Imaging). Circulation. 2003;108:1404–18.

  35. Yancy CW, Jessup M, Bozkurt B,  et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation.2013;128:e240–327.

  36. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–3128.

  37. Kown MH, Strauss HW, Blankenberg FG, et al. In vivo imaging of acute cardiac rejection in human patients using (99m) technetium labeled annexin V. Am J Transplant.2001;1:270–7.

  38. Yang M-F, Xie B-Q, Xiao-Dong Lv, et al. The role of myocardial viability assessed by perfusion/F-18 FDG imaging in children with anomalous origin of the left coronary artery from the pulmonary artery. Clin Nucl Med. 2012;37:44–8.

  39. Pizzi MN, Franquet E, Aguadé-Bruix S, et al. Long-term follow-up assessment after the arterial switch operation for correction of dextro-transposition of the great arteries by means of exercise myocardial perfusion-gated SPECT. Pediatr Cardiol 2014;35:197–207.

  40. Lim CWT, Ho KT, Quek SC. Exercise myocardial perfusion stress testing in children with Kawasaki disease. J Paediatr Child Health.2006;42:419–22.

  41. Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet. 2009;374:1462–71.

    Article  CAS  PubMed  Google Scholar 

  42. Movahed MR, Hepner A, Lizotte P, Milne N. Flattening of the interventricular septum (D-shaped left ventricle) in addition to high right ventricular tracer uptake and increased right ventricular volume found on gated SPECT studies strongly correlates with right ventricular overload. J Nucl Cardiol. 2005.12:428–34. 

  43. Parker JA, Coleman RE, Grady E, et al. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol. 2012;40:57–65.

  44. Pinho DF, Banga A, Torres F, Mathews D. Ventilation perfusion pulmonary scintigraphy in the evaluation of pre-and post-lung transplant patients. Transplant Rev (Orlando). 2019;33:107–14.

    Article  Google Scholar 

  45. Thacker PG, Lee EY. Pulmonary embolism in children. AJR Am J Roentgenol. 2015;204:1278–88. 

  46. Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Ann ICRP. 2015;44:7–321.

  47. Tulchinsky M, Fotos JS, Wechalekar K, Dadparvar S. Applications of ventilation-perfusion scintigraphy in surgical management of chronic obstructive lung disease and cancer. Semin Nucl Med. 2017;47:671–679.

  48. Olsen GN, Block AJ, Tobias JA. Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest. 1974;66:13–6.

    Article  CAS  PubMed  Google Scholar 

  49. Chien K-J, Huang H-W, Huang T-C,  et al. Assessment of branch pulmonary artery stenosis in children after repair of tetralogy of Fallot using lung perfusion scintigraphy comparison with echocardiography. Ann Nucl Med. 2016;30:49–59.

  50. Sridharan S, Derrick G, Deanfield J, Taylor AM. Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging. Heart. 2006;92:963–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Fathala A. Quantitative lung perfusion scintigraphy in patients with congenital heart disease. Heart Views. 2010;11:109–14.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Yin Z, Wang H, Wang Z, et al. Radionuclide and angiographic assessment of pulmonary perfusion after Fontan procedure: Comparative interim outcomes. Ann Thorac Surg.2012;93:620–5. 

  53. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57.

    PubMed  Google Scholar 

  54. Prevot N, Tiffet O, Avet J Jr, Quak E, Decousus M, Dubois F. Lymphoscintigraphy and SPECT/CT using 99mTc filtered sulphur colloid in chylothorax. Eur J Nucl Med Mol Imaging. 2011;38:1746.

  55. Yang J, Codreanu I, Zhuang H. Minimal lymphatic leakage in an infant with chylothorax detected by lymphoscintigraphy SPECT/CT. Pediatrics. 2014;134:e606–10.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Cardiothoracic and Vascular Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India

    Anand Kumar Mishra, Vidur Bansal & Javid Raja

  2. Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Harpreet Singh & Ashwani Sood

Authors
  1. Anand Kumar Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harpreet Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vidur Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Javid Raja
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ashwani Sood
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

1. AKM — manuscript writing.

2. HS — conceptualization.

3. VB — manuscript writing.

4. JR — manuscript editing.

5. AS — manuscript editing.

Corresponding author

Correspondence to Vidur Bansal.

Ethics declarations

Ethical approval

This manuscript was approved by the departmental ethics committee.

Informed consent

Not applicable.

Conflict of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mishra, A.K., Singh, H., Bansal, V. et al. Nuclear cardiology for a cardiothoracic surgeon. Indian J Thorac Cardiovasc Surg 38, 268–282 (2022). https://doi.org/10.1007/s12055-021-01311-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-021-01311-0

Keywords

Search

Navigation